Transthyretin Amyloid Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Transthyretin Amyloid Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-20Clinical Trial Update: ION-682884 in Patients With TTR Amyloid Cardiomyopathy [Phase 2]
A Phase 2 trial of ION-682884 for transthyretin amyloid cardiomyopathy has been withdrawn.